This suggests that physiologic ATDC overexpression (similar to that seen in human tumors) is sufficient to accelerate Kras-mediated tumorigenesis and enhance metastasis in the absence of common alterations in tumor suppressors in PDAC. This evidence concerns the gene KRAS and neoplasm.